Physical and emotional quality of life in children with B-acute lymphoblastic leukemia randomized to every 4- vs. 12-week vincristine/dexamethasone during maintenance: Children’s Oncology Group AALL0932.

Authors

null

Lyn M. Balsamo

Yale University, New Haven, CT

Lyn M. Balsamo , John A Kairalla , Emily Hibbitts , Rozalyn L Rodwin , Meenakshi Devidas , Alexandra Dreyzin , Naomi J. Winick , William L. Carroll , Stephen Hunger , Elizabeth A. Raetz , Reuven J. Schore , Mignon L. Loh , Kirsten K. Ness , Anne L. Angiolillo , Nina S. Kadan-Lottick

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Leukemia/Lymphoma

Clinical Trial Registration Number

NCT01190930

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 10025)

DOI

10.1200/JCO.2023.41.16_suppl.10025

Abstract #

10025

Poster Bd #

331

Abstract Disclosures

Similar Posters

First Author: Rohit Gupta

Poster

2024 ASCO Annual Meeting

Neurofilament light chains: A biomarker for vincristine-related neuropathy.

Neurofilament light chains: A biomarker for vincristine-related neuropathy.

First Author: Gretchen A McNally